On a down day for the market Wednesday, pickings were slim in the new high list but several quality names made the cut. Acadia Healthcare (ACHC) added 0.20 to 65.59. It hasn't made much progress yet after a breakout over a handle buy point of 65.55, but its technical picture is still intact. The ...

Hospital stocks had a strong day Wednesday as the Supreme Court listened to arguments on a major challenge to ObamaCare's insurance subsidies. Critical comments from Justice Anthony Kennedy helped fuel the charge. The group, home to nine stocks, still carries a low rank based on six-month price ...

Stocks appeared set for a second straight loss Wednesday after weaker-than-expected jobs data raised concerns about Friday's key nonfarm payrolls report. The Dow Jones industrial average was down 0.7%, the S&P 500 shed 0.6% and the Nasdaq slipped 0.3%. All cut early losses by more than half. ...

Stocks continued to pare losses in afternoon trading Wednesday amid mixed economic data. The Dow Jones industrial average and the S&P 500 shed 0.4% each and the Nasdaq slipped 0.2%. All cut early losses by more than half. Volume was mixed, up 3% on the NYSE and down 9% on the Nasdaq compared ...

In a report published Thursday, Leerink analyst Ana Gupte, Ph.D. detailed a conference call with MEDACorp specialists following the Supreme Court's oral arguments on the challenge to the Federal Exchange Subsidies. Latest Ratings for CNC ...

DISCLAIMER

The information expressed in this service is based upon the interpretation of available data. The data being presented was obtained or derived from sources believed to be accurate, but Investor's Business Daily can not and does not guarantee the accuracy of these sources which may be incomplete and/or condensed. The data and information presented is provided for informational purposes only, and is not offered as a basis for trading in securities nor is it offered for that purpose. Users of the Service should conduct their own independent investigation before making any investment or business decisions with respect to securities covered by the Service. Test Neither Investor's Business Daily nor any of its data or content providers shall be liable for any errors in the information or delays in its delivery, or for any action taken in reliance thereon. Nothing contained herein should be construed as a recommendation to buy or sell any securities.